Moods Disorders Completed Phase 2 Trials for Lamotrigine (DB00555)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001482New Drugs in the Treatment of Mood DisordersTreatment